Ovarian cysts in users of Implanon® and Jadelle® subdermal contraceptive implants

Contraception

Volumn 73, Issue 5, 2006, Pages 532-536

  Hidalgo, Maria Margarete ^a   Lisondo, Claudio ^a   Juliato, Cássia Teatin ^a   Espejo Arce, Ximena ^a   Monteiro, Ilza ^a   Bahamondes, Luis ^a  

^a Department of Obstetrics and Gynecology School of Medicine Universida de Estadual de Campinas   (Brazil)

Author keywords

Contraceptive implants; Implanon ; Jadelle ; Ovarian follicles

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL; ETONOGESTREL; LEVONORGESTREL; PROGESTERONE;

ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IMPLANT; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; MAJOR CLINICAL STUDY; MENORRHAGIA; OVARY CYST; OVARY FOLLICLE; OVARY HYPERTROPHY; TIME SERIES ANALYSIS; ULTRASOUND;

ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAUTERINE DEVICES; OVARIAN CYSTS; PROGESTINS; PROSPECTIVE STUDIES;

EID: 33646030596     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.12.012     Document Type: Article

References (22)

1. Meirik O., Farley T.M., and Sivin I. Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization. Obstet Gynecol 97 (2001) 539-547
2. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. (2004), WHO, Geneva
3. Croxatto H.B. Progestin implants. Steroids 65 (2000) 681-685
4. Brache V., Faúndes A., Johansson E., and Alvarez F. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant® implants. Contraception 31 (1985) 261-273
5. Croxatto H.B., Diaz S., Salvatierra A.M., Morales P., Ebensperger C., and Brandeis A. Treatment with Norplant® subdermal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 36 (1987) 193-201
6. Alvarez F., Brache V., Tejada A.S., and Faúndes A. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant® use. Contraception 33 (1986) 111-119
7. Brache V., Alvarez-Sanchez F., Faúndes A., Tejada A.S., and Cochon L. Ovarian endocrine function through five years of continuous treatment with Norplant® subdermal contraceptive implants. Contraception 41 (1990) 169-177
8. Croxatto H.B., Diaz S., Pavez M., Miranda P., and Brandeis A. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants. Acta Endocrinol 101 (1982) 307-311
9. Shoupe D., Horenstein H., Mishell Jr. D.R., Lacarra M., and Medearis A. Characteristics of ovarian follicular development in Norplant® users. Fertil Steril 55 (1991) 766-770
10. Croxatto H.B., and Makarainen L. The pharmacodynamics and efficacy of Implanon®: an overview of the data. Contraception 58 (1998) 91S-97S
11. Bahamondes L., Hidalgo M., Petta C.A., Diaz J., Espejo-Arce X., and Monteiro-Dantas C. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant. J Reprod Med 48 (2003) 637-640
12. Inki P., Hurskainen R., Palo P., et al. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Ultrasound Obstet Gynecol 20 (2002) 381-385
13. Alvarez F., Brache V., Faundes A., Tejada A.S., and Thevenin F. Ultrasonographic and endocrine evaluation of ovarian function among Norplant® implants users with regular menses. Contraception 54 (1996) 275-279
14. Alvarez-Sanchez F., Brache V., Montes de Oca V., Cochon L., and Faundes A. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant). Am J Obstet Gynecol 182 (2000) 535-539
15. Belsey E.M., Machin D., and D'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 34 (1986) 253-260
16. Israel R., Mishell Jr. D.R., Stone S.C., Thorneycroft I.H., and Moyer D.L. Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynecol 112 (1972) 1043-1046
17. Makarainen L., van Beek A., Tuomivaara L., Asplund B., and Bennink H.C. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril 69 (1998) 714-721
18. Shaaban M.M., Segal S., Salem H., Ghaneimah S.A., Khalifa E.A., and Ahmed A.G. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Fertil Steril 59 (1993) 998-1002
19. Faundes A., Alvarez F., Brache V., and Cochon L. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant® implants. Hum Reprod 13 (1998) 188-191
20. Mascarenhas L., van Beek A., Bennink H.C., and Newton J.A. A two-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK. Hum Reprod 13 (1998) 3057-3060
21. Christensen J.T., Boldsen J.L., and Westergaard J.G. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 66 (2002) 153-157
22. Borgfeldt C., and Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol 13 (1999) 345-350